Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Jul 6;12(7):e9031.
doi: 10.7759/cureus.9031.

Bilateral Nephrectomy, the Forgotten Measure in the Treatment of Refractory Hypertension in Patients With End-Stage Renal Disease: A Case Report and Literature Review

Mohammad Aldiabat  1 , Khaled Alabdallah  1 , Ahmad Kofahi  1 , Shazia Aziz  1
Affiliations
Case Reports

Bilateral Nephrectomy, the Forgotten Measure in the Treatment of Refractory Hypertension in Patients With End-Stage Renal Disease: A Case Report and Literature Review

Mohammad Aldiabat et al. Cureus. .

Abstract

It's not uncommon for patients with end-stage renal disease (ESRD) to develop hypertension that is resistant to antihypertensive medications and volume control, making it a challenge to control blood pressure in those patients. In this article, we present a 71-year-old female with a history of ESRD on intermittent hemodialysis (IHD), who developed refractory hypertension despite the use of seven antihypertensive agents in addition to IHD. The patient underwent bilateral nephrectomy as a last resort therapy for managing resistant hypertension, which led to a significant improvement in blood pressure (BP) and decreasing the number and doses of antihypertensive agents. This article aims to raise the awareness and alertness of clinicians to the efficacy of bilateral nephrectomy as rescue therapy for refractory hypertension in hemodialysis patients.

Keywords: bilateral nephrectomy; end stage renal disease (esrd); hemodialysis; high blood pressure; polycystic kidney disease; refractory hypertension; resistant hypertension.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. CT abdomen showing the severe cystic appearance of both kidneys (white arrows)
CT: computed tomography
See this image and copyright information in PMC

References

    1. Resistant hypertension: detection, evaluation, and management: a scientific statement from the American Heart Association. Carey RM, Calhoun DA, Bakris GL, et al. https://www.ahajournals.org/doi/10.1161/HYP.0000000000000084 Hypertension. 2018;72:53–90. - PMC - PubMed
    1. Refractory hypertension. A novel phenotype of antihypertensive treatment failure. Dudenbostel T, Siddiqui M, Oparil S, Calhoun DA. https://www.ahajournals.org/doi/10.1161/HYPERTENSIONAHA.116.06587. Hypertension. 2016;67:1085–1092. - PMC - PubMed
    1. Central iliac arteriovenous anastomosis for uncontrolled hypertension. One-year results from the ROX CONTROL HTN trial. Lobo MD, Ott C, Sobotka PA, et al. https://pubmed.ncbi.nlm.nih.gov/29061728/ Hypertension. 2017;70:1099–1105. - PubMed
    1. Bilateral nephrectomy: the best, but often overlooked, treatment for refractory hypertension in hemodialysis patients. Zazgornik J, Biesenbach G, Janko O, et al. https://academic.oup.com/ajh/article/11/11/1364/145831. Am J Hypertens. 1998;11:1364–1370. - PubMed
    1. Prevalence of apparent treatment-resistant hypertension among individuals with CKD. Tanner RM, Calhoun DA, Bell EK, et al. Clin J Am Soc Nephrol. 2013;8:1583–1590. - PMC - PubMed

Publication types